Skip to main content

Advertisement

Log in

Effect of Dietary Intake Through Whole Foods on Cognitive Function: Review of Randomized Controlled Trials

  • Nutrition and the Brain (J Nasser, Section Editor)
  • Published:
Current Nutrition Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review evaluated recent randomized controlled trials (RCTs) examining the chronic intake of whole foods associated with the Mediterranean, Dietary Approaches to Stop Hypertension (DASH), Mediterranean-DASH Intervention for Neurogenerative Delay (MIND), and ketogenic (KETO) diets on cognitive function.

Recent Findings

We identified RCTs related to olive oil (N = 3), nuts (N = 7), fatty fish (N = 1), lean meats (N = 4), fruits and vegetables (N = 9), legumes (N = 1), and low-fat dairy (N = 4), with 26/29 reporting positive results on at least one measure of cognition. We also identified 6 RCTs related to whole food–induced KETO diets, with half reporting positive effects on cognition.

Summary

Variations in study design (i.e., generally the studies are < 6 months and include middle-aged and older, cognitively intact participants) and small sample sizes make it difficult to draw conclusions across studies; however, the current evidence from RCTs generally supports individual component intakes of these dietary patterns as an effective, nonpharmacological approach to improve cognitive health in adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance ••Of major importance

  1. Flanagan E, Lamport D, Brennan L, Burnet P, Calabrese V, Cunnane SC, et al. Nutrition and the ageing brain: moving towards clinical applications. Ageing Res Rev. 2020;62:101079.

  2. • Serra MC, Dondero KR, Larkins D, Burns A, Addison O. Healthy lifestyle and cognition: interaction between diet and physical activity. Curr Nutr Rep. 2020;9(2):64–74. This review supports adherence to specific dietary patterns (MEDI, DASH, MIND) and a combination of aerobic and resistance exercise, both individually and combined, as an effective approach to mitigate age-associated cognitive decline. It highlights observational evidence between diet adherence and positive cognitive outcomes related to memory, executive function, and risk for cognitive impairment. It also highlights improvements in cognitive performance after exercise interventions regardless of baseline cognitive status and notes lower incidences of cognitive impairment in people who engage in regular physical activity.

  3. Cremonini AL, Caffa I, Cea M, Nencioni A, Odetti P, Monacelli F. Nutrients in the prevention of Alzheimer’s disease. Oxid Med Cell Longev. 2019;2019:9874159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. • van den Brink AC, Brouwer-Brolsma EM, Berendsen AAM, van de Rest O. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer’s disease-a review. Adv Nutr. 2019;10(6):1040–65. A recent review summarizes the evidence examining an association between various dietary patterns (i.e., MEDI, DASH, and MIND) with cognitive decline, dementia, and Alzheimer’s disease (AD) across 56 studies. In general, the authors report that higher adherence to these diets is associated with better cognitive scores and lower risk for dementia and AD, where the strongest associations are observed for the MIND diet. For the components of these dietary patterns, the authors suggest that olive oil may be associated with less cognitive decline.

  5. • Vinciguerra F, Graziano M, Hagnäs M, Frittitta L, Tumminia A. Influence of the Mediterranean and ketogenic diets on cognitive status and decline: a narrative review. Nutrients. 2020;12(4). This review highlights the existing research on the efficacy of MEDI and KETO diets against AD-related cognitive decline and focuses on the proposed protective mechanisms of action. It summarizes that despite the different underlying mechanisms, both MEDI and KETO diets demonstrated a beneficial role in reducing or delaying cognitive impairment. It predicts that information could be of help to better characterize the possible role of MEDI and KETO diets as nonpharmacological therapies in the treatment of AD and, more generically, of neurodegenerative disorders.

  6. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2020– 2025 Dietary Guidelines for Americans. 9th Edition. 2020.

  7. Strings Attached: CADTH’s Database Search Filters. Randomized Controlled Trials — PubMed. Ottawa: CADTH. 2021.

  8. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71.

  9. Ammar A, Trabelsi K, Müller P, Bouaziz B, Boukhris O, Glenn JM, et al. The effect of (poly)phenol-rich interventions on cognitive functions and neuroprotective measures in healthy aging adults: a systematic review and meta-analysis. J Clin Med. 2020;9(3).

  10. Wu L, Sun D. Adherence to Mediterranean diet and risk of developing cognitive disorders: an updated systematic review and meta-analysis of prospective cohort studies. Sci Rep. 2017;7:41317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Martínez-Lapiscina EH, Clavero P, Toledo E, San Julián B, Sanchez-Tainta A, Corella D, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging. 2013;17(6):544–52.

    Article  PubMed  Google Scholar 

  12. Tsolaki M, Lazarou E, Kozori M, Petridou N, Tabakis I, Lazarou I, et al. A randomized clinical trial of Greek high phenolic early harvest extra virgin olive oil in mild cognitive impairment: The MICOIL pilot study. J Alzheimers Dis. 2020;78(2):801–17.

    Article  CAS  PubMed  Google Scholar 

  13. Mazza E, Fava A, Ferro Y, Rotundo S, Romeo S, Bosco D, et al. Effect of the replacement of dietary vegetable oils with a low dose of extravirgin olive oil in the Mediterranean diet on cognitive functions in the elderly. J Transl Med. 2018;16(1):10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martínez-González M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094–103.

    Article  PubMed  Google Scholar 

  15. Martínez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, San Julián B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84(12):1318–25.

    Article  PubMed  Google Scholar 

  16. Bishop NJ, Zuniga KE. Investigating walnut consumption and cognitive trajectories in a representative sample of older US adults. Public Health Nutr. 2021;24(7):1741–52.

    Article  PubMed  Google Scholar 

  17. Barbour JA, Howe PRC, Buckley JD, Bryan J, Coates AM. Cerebrovascular and cognitive benefits of high-oleic peanut consumption in healthy overweight middle-aged adults. Nutr Neurosci. 2017;20(10):555–62.

    Article  CAS  PubMed  Google Scholar 

  18. • Sala-Vila A, Valls-Pedret C, Rajaram S, Coll-Padrós N, Cofán M, Serra-Mir M, et al. Effect of a 2-year diet intervention with walnuts on cognitive decline. The Walnuts And Healthy Aging (WAHA) study: a randomized controlled trial. Am J Clin Nutr. 2020;111(3):590–600. Two-year longitudinal RCT (N=636), which examines the cognitive effects of walnut consumption vs. a control (abstention from walnuts) in cognitively healthy, older adults (63–79 years). No group differences for global cognition are observed. However, the authors suggest that walnuts might delay cognitive decline in subgroups at higher risk (i.e., smoked more, less educated).

  19. Pribis P, Bailey RN, Russell AA, Kilsby MA, Hernandez M, et al. Effects of walnut consumption on cognitive performance in young adults. Br J Nutr. 2012;107(9):1393–401.

  20. Dhillon J, Tan SY, Mattes RD. Effects of almond consumption on the post-lunch dip and long-term cognitive function in energy-restricted overweight and obese adults. Br J Nutr. 2017;117(3):395–402.

    Article  CAS  PubMed  Google Scholar 

  21. Coates AM, Morgillo S, Yandell C, Scholey A, Buckley JD, Dyer KA, et al. Effect of a 12-week almond-enriched diet on biomarkers of cognitive performance, mood, and cardiometabolic health in older overweight adults. Nutrients. 2020;12(4).

  22. Mustra Rakic J, Tanprasertsuk J, Scott TM, Rasmussen HM, Mohn ES, Chen CYO, et al. Effects of daily almond consumption for six months on cognitive measures in healthy middle-aged to older adults: a randomized control trial. Nutr Neurosci. 2021:1–11.

  23. Rita Cardoso B, Apolinário D, da Silva BV, Busse AL, Magaldi RM, Jacob-Filho W, et al. Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial. Eur J Nutr. 2016;55(1):107–16.

    Article  CAS  PubMed  Google Scholar 

  24. Weiser MJ, Butt CM, Mohajeri MH. Docosahexaenoic acid and cognition throughout the lifespan. Nutrients. 2016;8(2):99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hansen AL, Ambroziak G, Thornton D, Dahl L, Grung B. Age and IQ explained working memory performance in a RCT with fatty fish in a group of forensic inpatients. J Nutr Health Aging. 2018;22(4):513–8.

    Article  CAS  PubMed  Google Scholar 

  26. Hansen AL, Dahl L, Olson G, Thornton D, Grung B, Thayer JF. A long-term fatty fish intervention improved executive function in inpatients with antisocial traits and a history of alcohol and drug abuse. Scand J Psychol. 2015;56(5):467–74.

    Article  PubMed  Google Scholar 

  27. Moore K, Hughes CF, Ward M, Hoey L, McNulty H. Diet, nutrition and the ageing brain: current evidence and new directions. Proc Nutr Soc. 2018;77(2):152–63.

    Article  PubMed  Google Scholar 

  28. Roberts RO, Roberts LA, Geda YE, Cha RH, Pankratz VS, O’Connor HM, et al. Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. J Alzheimers Dis. 2012;32(2):329–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Charlton K, Walton K, Batterham M, Brock E, Langford K, McMahon A, et al. Pork and chicken meals similarly impact on cognitive function and strength in community-living older adults: a pilot study. J Nutr Gerontol Geriatr. 2016;35(2):124–45.

    Article  PubMed  Google Scholar 

  30. Blanton C. Improvements in iron status and cognitive function in young women consuming beef or non-beef lunches. Nutrients. 2013;6(1):90–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Derbyshire E. Associations between red meat intakes and the micronutrient intake and status of UK females: a secondary analysis of the UK National Diet and Nutrition Survey. Nutrients. 2017;9(7):768.

    Article  CAS  PubMed Central  Google Scholar 

  32. Wade AT, Davis CR, Dyer KA, Hodgson JM, Woodman RJ, Keage HAD, et al. A Mediterranean diet with fresh, lean pork improves processing speed and mood: cognitive findings from the MedPork randomised controlled trial. Nutrients. 2019;11(7).

  33. Formica MB, Gianoudis J, Nowson CA, O’Connell SL, Milte C, Ellis KA, et al. Effect of lean red meat combined with a multicomponent exercise program on muscle and cognitive function in older adults: a 6-month randomized controlled trial. Am J Clin Nutr. 2020;112(1):113–28.

    Article  PubMed  Google Scholar 

  34. Edwards CG, Walk AM, Thompson SV, Reeser GE, Erdman JW Jr, Burd NA, et al. Effects of 12-week avocado consumption on cognitive function among adults with overweight and obesity. Int J Psychophysiol. 2020;148:13–24.

    Article  PubMed  Google Scholar 

  35. Scott TM, Rasmussen HM, Chen O, Johnson EJ. Avocado consumption increases macular pigment density in older adults: a randomized, controlled trial. Nutrients. 2017;9(9).

  36. Neshatdoust S, Saunders C, Castle SM, Vauzour D, Williams C, Butler L, et al. High-flavonoid intake induces cognitive improvements linked to changes in serum brain-derived neurotrophic factor: two randomised, controlled trials. Nutrition and healthy aging. 2016;4(1):81–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Krikorian R, Boespflug EL, Fleck DE, Stein AL, Wightman JD, Shidler MD, et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem. 2012;60(23):5736–42.

    Article  CAS  PubMed  Google Scholar 

  38. Lamport DJ, Lawton CL, Merat N, Jamson H, Myrissa K, Hofman D, et al. Concord grape juice, cognitive function, and driving performance: a 12-wk, placebo-controlled, randomized crossover trial in mothers of preteen children. Am J Clin Nutr. 2016;103(3):775–83.

    Article  CAS  PubMed  Google Scholar 

  39. Bowtell JL, Aboo-Bakkar Z, Conway ME, Adlam AR, Fulford J. Enhanced task-related brain activation and resting perfusion in healthy older adults after chronic blueberry supplementation. Appl Physiol Nutr Metab. 2017;42(7):773–9.

    Article  CAS  PubMed  Google Scholar 

  40. Nilsson A, Salo I, Plaza M, Björck I. Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; a randomized cross-over study in healthy older adults. PloS one. 2017;12(11):e0188173.

  41. Siddarth P, Li Z, Miller KJ, Ercoli LM, Merril DA, Henning SM, et al. Randomized placebo-controlled study of the memory effects of pomegranate juice in middle-aged and older adults. Am J Clin Nutr. 2020;111(1):170–7.

    PubMed  Google Scholar 

  42. Kean RJ, Lamport DJ, Dodd GF, Freeman JE, Williams CM, Ellis JA, et al. Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: an 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. Am J Clin Nutr. 2015;101(3):506–14.

    Article  CAS  PubMed  Google Scholar 

  43. Lee YB, Lee HJ, Sohn HS. Soy isoflavones and cognitive function. J Nutr Biochem. 2005;16(11):641–9.

    Article  CAS  PubMed  Google Scholar 

  44. Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, et al. Effect of S-equol and Soy Isoflavones on Heart and Brain. Curr Cardiol Rev. 2019;15(2):114–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Mirahmadi SM, Shahmohammadi A, Rousta AM, Azadi MR, Fahanik-Babaei J, Baluchnejadmojarad T, et al. Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects. Cytokine. 2018;104:151–9.

    Article  CAS  PubMed  Google Scholar 

  46. Bonet-Costa V, Herranz-Pérez V, Blanco-Gandía M, Mas-Bargues C, Inglés M, Garcia-Tarraga P, et al. Clearing amyloid-β through PPARγ/ApoE activation by genistein is a treatment of experimental Alzheimer’s disease. J Alzheimers Dis. 2016;51(3):701–11.

    Article  CAS  PubMed  Google Scholar 

  47. Ye S, Wang TT, Cai B, Wang Y, Li J, Zhan JX, et al. Genistein protects hippocampal neurons against injury by regulating calcium/calmodulin dependent protein kinase IV protein levels in Alzheimer’s disease model rats. Neural Regen Res. 2017;12(9):1479–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wang Y, Cai B, Shao J, Wang TT, Cai RZ, Ma CJ, et al. Genistein suppresses the mitochondrial apoptotic pathway in hippocampal neurons in rats with Alzheimer’s disease. Neural Regen Res. 2016;11(7):1153–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kleinloog JPD, Tischmann L, Mensink RP, Adam TC, Joris PJ. Longer-term soy nut consumption improves cerebral blood flow and psychomotor speed: results of a randomized, controlled crossover trial in older men and women. Am J Clin Nutr. 2021;114(6):2097–106.

    Article  PubMed Central  Google Scholar 

  50. • Cui C, Birru RL, Snitz BE, Ihara M, Kakuta C, Lopresti BJ, et al. Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2020;78(2):134–44. This meta-analysis examines the role of isoflavones in reducing levels of inflammation and oxidative stress, and suppressing the mitochondrial apoptotic pathway which alleviates cognitive impairment. The results show that isoflavones may improve cognitive function, in adult men and women (i.e., better performance in neuropsychological batteries) than the control groups and the effect is pronounced in the domain of memory.

  51. Ozawa M, Shipley M, Kivimaki M, Singh-Manoux A, Brunner EJ. Dietary pattern, inflammation and cognitive decline: the Whitehall II prospective cohort study. Clinical nutrition (Edinburgh, Scotland). 2017;36(2):506–12.

    Article  Google Scholar 

  52. Fortune NC, Harville EW, Guralnik JM, Gustat J, Chen W, Qi L, et al. Dietary intake and cognitive function: evidence from the Bogalusa Heart Study. Am J Clin Nutr. 2019;109(6):1656–63.

    Article  PubMed  PubMed Central  Google Scholar 

  53. • Tieri M, Ghelfi F, Vitale M, Vetrani C, Marventano S, Lafranconi A, et al. Whole grain consumption and human health: an umbrella review of observational studies. International Journal of Food Sciences and Nutrition. 2020;71(6):668–77. This review highlights the existing meta-analysis of observational studies and suggests that a dietary intake of whole grain is associated with better cognitive function.

  54. Lee J, Fu Z, Chung M, Jang DJ, Lee HJ. Role of milk and dairy intake in cognitive function in older adults: a systematic review and meta-analysis. Nutr J. 2018;17(1):82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Annweiler C, Dursun E, Féron F, Gezen-Ak D, Kalueff AV, Littlejohns T, et al. ‘Vitamin D and cognition in older adults’: updated international recommendations. J Intern Med. 2015;277(1):45–57.

    Article  CAS  PubMed  Google Scholar 

  56. Soni M, Kos K, Lang IA, Jones K, Melzer D, Llewellyn DJ. Vitamin D and cognitive function. Scand J Clin Lab Invest Suppl. 2012;243:79–82.

    PubMed  Google Scholar 

  57. Wade AT, Davis CR, Dyer KA, Hodgson JM, Woodman RJ, Keage HAD, et al. A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample: results from the MedDairy randomized controlled trial. Nutr Neurosci. 2018;23(8):646–58.

    Article  PubMed  Google Scholar 

  58. Crichton GE, Murphy KJ, Howe PR, Buckley JD, Bryan J. Dairy consumption and working memory performance in overweight and obese adults. Appetite. 2012;59(1):34–40.

    Article  PubMed  Google Scholar 

  59. Beauchet O, Launay CP, Galery K, Vilcocq C, Dontot-Payen F, Rousseau B, et al. Effects of vitamin D and calcium fortified yogurts on gait, cognitive performances, and serum 25-hydroxyvitamin D concentrations in older community-dwelling females: results from the GAit, MEmory, Dietary and Vitamin D (GAME-D2) randomized controlled trial. Nutrients. 2019;11(12).

  60. Ichinose T, Matsuzaki K, Kato M, Tanabe Y, Tachibana N, Morikawa M, et al. Intake of docosahexaenoic acid-enriched milk beverage prevents age-related cognitive decline and decreases serum bone resorption marker levels. J Oleo Sci. 2021;70(12):1829–38.

    Article  CAS  PubMed  Google Scholar 

  61. • Reale M, Costantini E, Jagarlapoodi S, Khan H, Belwal T, Cichelli A. Relationship of Wine Consumption with Alzheimer's Disease. Nutrients. 2020;12(1):206. This review summarizes the existing cross-sectional and observational studies on the association between the consumption of wine and AD, as well as how frequency and/or amount of drinking may influence the relationship. The study concludes that light-to-moderate wine consumption, preferably red wine, appears to reduce the risk of cognitive decline in an age-dependent manner, while the excessive intake is associated with increased risk for dementia.

  62. Broom GM, Shaw IC, Rucklidge JJ. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease. Nutrition. 2019;60:118–21.

    Article  CAS  PubMed  Google Scholar 

  63. • McDonald TJW, Cervenka MC. Lessons learned from recent clinical trials of ketogenic diet therapies in adults. Current opinion in clinical nutrition and metabolic care. 2019;22(6):418–24. This recent review suggests that the KETO diet (high fat, low carbohydrate) shows promise for a variety of clinical indications. Further, nutritional ketosis without comprehensive diet modification improves cognition and cerebral blood flow in patients’ cognitive status and dementia.

  64. Davis JJ, Fournakis N, Ellison J. Ketogenic diet for the treatment and prevention of dementia: a review. J Geriatr Psychiatry Neurol. 2021;34(1):3–10.

    Article  PubMed  Google Scholar 

  65. Jensen NJ, Wodschow HZ, Nilsson M, Rungby J. Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci. 2020;21(22).

  66. Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Ketogenic diet in Alzheimer’s disease. Int J Mol Sci. 2019;20(16).

  67. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Investig. 1967;46(10):1589–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep. 2013;13(4):342.

    Article  CAS  PubMed  Google Scholar 

  69. Hildreth KL, Van Pelt RE, Schwartz RS. Obesity, insulin resistance, and Alzheimer’s disease. Obesity (Silver Spring, Md). 2012;20(8):1549–57.

    Article  CAS  Google Scholar 

  70. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, et al. Insulin, ketone bodies, and mitochondrial energy transduction. Faseb j. 1995;9(8):651–8.

    Article  CAS  PubMed  Google Scholar 

  71. Haces ML, Hernández-Fonseca K, Medina-Campos ON, Montiel T, Pedraza-Chaverri J, Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol. 2008;211(1):85–96.

    Article  CAS  PubMed  Google Scholar 

  72. Shen Y, Kapfhamer D, Minnella AM, Kim JE, Won SJ, Chen Y, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun. 2017;8(1):624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, Luhovyy B, et al. Response of brain amino acid metabolism to ketosis. Neurochem Int. 2005;47(1–2):119–28.

    Article  CAS  PubMed  Google Scholar 

  74. Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer’s disease. Nutr Metab (Lond). 2005;2:28.

    Article  CAS  Google Scholar 

  75. Seneff S, Wainwright G, Mascitelli L. Nutrition and Alzheimer’s disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med. 2011;22(2):134–40.

    Article  CAS  PubMed  Google Scholar 

  76. Li YM, Dickson DW. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer’s disease. Neurosci Lett. 1997;226(3):155–8.

    Article  CAS  PubMed  Google Scholar 

  77. Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012;33(2):425.e19-27.

    Article  CAS  Google Scholar 

  79. Morrison SA, Fazeli PL, Gower B, Willig AL, Younger J, Sneed NM, et al. Cognitive effects of a ketogenic diet on neurocognitive impairment in adults aging with HIV: a pilot study. The Journal of the Association of Nurses in AIDS Care: JANAC. 2020;31(3):312–24.

    Article  PubMed  Google Scholar 

  80. Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimers Res Ther. 2021;13(1):51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Makris A, Darcey VL, Rosenbaum DL, Komaroff E, Vander Veur SS, Collins BN, et al. Similar effects on cognitive performance during high- and low-carbohydrate obesity treatment. Nutr Diabetes. 2013;3(9):e89.

  82. Tay J, Zajac IT, Thompson CH, Luscombe-Marsh ND, Danthiir V, Noakes M, et al. A randomised-controlled trial of the effects of very low-carbohydrate and high-carbohydrate diets on cognitive performance in patients with type 2 diabetes. Br J Nutr. 2016:1-9.

  83. Iacovides S, Goble D, Paterson B, Meiring RM. Three consecutive weeks of nutritional ketosis has no effect on cognitive function, sleep, and mood compared with a high-carbohydrate, low-fat diet in healthy individuals: a randomized, crossover, controlled trial. Am J Clin Nutr. 2019;110(2):349–57.

    Article  PubMed  Google Scholar 

  84. Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, et al. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer’s disease patients with APOE4(-/-): a double-blind, randomized, placebo-controlled crossover trial. Clin Nutr. 2020;39(7):2092–105.

    Article  CAS  PubMed  Google Scholar 

  85. Gardner B, Lally P, Wardle J. Making health habitual: the psychology of ‘habit-formation’ and general practice. Br J Gen Pract. 2012;62(605):664–6.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Knight A, Bryan J, Wilson C, Hodgson J, Murphy K. A randomised controlled intervention trial evaluating the efficacy of a Mediterranean dietary pattern on cognitive function and psychological wellbeing in healthy older adults: the MedLey study. BMC Geriatr. 2015;15:55.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This review was supported by funds from the San Antonio Geriatric Research Education and Clinical Center and the Office of Academic Affiliations and with resources and the use of facilities of the South Texas Veterans Health Care System, San Antonio, TX.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rozmin Jiwani RN, PhD.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This is a review article and does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Nutrition and the Brain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiwani, R., Robbins, R., Neri, A. et al. Effect of Dietary Intake Through Whole Foods on Cognitive Function: Review of Randomized Controlled Trials. Curr Nutr Rep 11, 146–160 (2022). https://doi.org/10.1007/s13668-022-00412-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13668-022-00412-5

Keywords

Navigation